Menu

First RNAi Insecticide Approved

This month, the EPA registered four products that include RNA interference technology intended to control corn rootworms. 

Jun 27, 2017
Aggie Mika

WIKIMEDIA, TOM HLAVATY

   This month, the US Environmental Protection Agency (EPA) approved the first plant-incorporated protectant (PIP) of its kind based on RNA interference (RNAi) technology, engineered to target western corn rootworms (Diabrotica virgifera virgifera), The Atlantic reports. According to a statement issued this month (June 15) by the EPA, four SmartStax Pro seed products with the RNAi-based PIP have been registered thus far.

PIPs are pesticides that plants are able to produce themselves, thanks to modifications to the plants’ genes, according to the EPA. While some crops already contain RNAi-technology for the purposes of fending off certain viruses, among other uses, this is the first insecticide to take advantage of this technology.

See “Improving Crops with RNAi

RNAi is a ubiquitous process across plant and animal cells, during which short RNA molecules hinder gene expression by homing in on and subsequently cleaving their complementary messenger RNA transcripts.

See “RNA Interference Between Kingdoms

These SmartStax Pro corn seed products, The Atlantic reports, will incorporate DvSnf7 dsRNA. As prior research has demonstrated, this dsRNA, or double-stranded RNA, is specific to the western corn rootworm’s Snf7 gene. When a DvSnf7 dsRNA-containing plant is consumed by a corn rootworm, the dsRNA will initiate RNAi within the worm, leading to the suppression of this critical gene, and eventually, the rootworm’s demise.

The corn rootworm is “a devastating corn pest that has developed resistance to several other pesticides,” according to the EPA statement, that “can collectively cost corn growers in the U.S. over a billion dollars in terms of control costs and yield losses.”

According to The Atlantic, the EPA’s recent approval of the RNAi-based insecticide was “surprisingly low-key,” compared to the hullabaloo surrounding RNAi-based technology in the past. 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.